Jim Cramer - Mad Money Albireo Pharma ALBO-Q DON'T BUY Oct 19, 2020

A biopharma treating liver and gastrointestinal diseases. It's totally speculative in a very niche market. Even if it hits it out of the park in performance, you won't make much money.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$34.310

Stock price when the opinion was issued

Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money Albireo Pharma ALBO-Q DON'T BUY Oct 19, 2020

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights